ZYXI News and Press, Zynex Inc. From 04/28/22

Zynex press release (NASDAQ:ZYXI): Q1 GAAP EPS of $0.03 misses by $0.02. Revenue of $31.08M (+28.8% Y/Y) beats by $0.06M. Adjusted EBITDA increased 897% to $3.1 million Announced Share Buyback Program up to $10M over next 12 months. As of March 31, 2022, the Company had working capital of $59...

Zynex Announces 2022 First Quarter Earnings PR Newswire ENGLEWOOD, Colo. , April 28, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa...

Zynex, Inc. to Announce First Quarter 2022 Financial Results PR Newswire ENGLEWOOD, Colo. , April 18, 2022 /PRNewswire/ -- April 18, 2022 – Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufactur...

Trending Health Care Stocks To Watch In The Stock Market This Week As talks of a possible recession by the end of the year arise, investors could be thinking of rotating towards more defensive positions. As such, they could consider investing in health care stocks . This comes a...

Zynex (NASDAQ: ZYXI) board approved a $10M share buyback program. The program will commence April 12, 2022, and end April 11, 2023, or when the $10.0 million buyback limit is reached. Zynex CEO Thomas Sandgaard said, "We believe that the current market value of our shares does not accurately ...

Zynex (NASDAQ:ZYXI) has reported prelim Q1 revenues of $30.5M to $31.5M (consensus: $32.33M) and adj. EBITDA of $3M - $4M. The revenue estimate is ~26% higher than Q121 and adjusted EBITDA is estimated to increase ~900% Y/Y. The pain management division saw Q1 order growth of 3% Y/Y. March 20...

Zynex Reports Preliminary First Quarter 2022 Results and Provides Business Update PR Newswire ENGLEWOOD, Colo. , April 8, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sa...

One group stands out as an interesting and potentially dramatically undervalued area of the market in the wake of the pandemic and its historical footprint: Medical device stocks. The healthcare system has been forever changed by the pandemic, which accelerated several core healthcare industr...

Gainers: Sportradar Group AG (SRAD) +5%. Eargo, Inc. (EAR) +4%. Zynex, Inc. (ZYXI) +3%. IVERIC bio, Inc. (ISEE) +3%. Sono Group N.V. (SEV) +3%. Losers: Vir Biotechnology, Inc. (VIR) -8%. Jounce Therapeutics, Inc. (JNCE) -6%. Travelzoo (TZOO) -5%. Health Catalyst, Inc (HCAT) -4%...

Zynex Recognized as Fourth Largest Biotechnology/Bioscience Company in Colorado PR Newswire ENGLEWOOD, Colo. , March 23, 2022 /PRNewswire/ -- Zynex, Inc . ( Nasdaq: ZYXI ) an innovative medical technology company specializing in the manufacture and sa...